Nephrology

1-11 of 11

• 

  RestartResume

  Evaluating a HIF-PHI for Anemia in In-Center Hemodialysis

  Innovations In Medicine

  Evaluating a HIF-PHI for Anemia in In-Center Hemodialysis

  • 

    

    Matt Birnholz, MD

  • 

    

    Gates B. Colbert, MD

  • 

    

    Varshi Broumand, MD, FASN

• 

  RestartResume

  The Risk Equation: Combining uACR and eGFR for CV Prediction

  Conversations in CV Risk Assessment

  The Risk Equation: Combining uACR and eGFR for CV Prediction

  • 

    

    Matthew Sorrentino, MD

  • 

    

    Ashish Verma, MBBS

• 

  RestartResume

  Albuminuria: An Overlooked Red Flag in Cardiovascular Risk

  Conversations in CV Risk Assessment

  Albuminuria: An Overlooked Red Flag in Cardiovascular Risk

  • 

    

    Matthew Sorrentino, MD

  • 

    

    Ashish Verma, MBBS

• 

  RestartResume

  Hidden High Risk: When BP Control Isn’t Enough in Hypertension

  Conversations in CV Risk Assessment

  Hidden High Risk: When BP Control Isn’t Enough in Hypertension

  • 

    

    Gates B. Colbert, MD

  • 

    

    Michael E. Hall, MD

  • 

    

    Clyde W. Yancy, MD

• 

  RestartResume

  Rethinking Cardiovascular Risk: Uncovering the Blind Spots

  Conversations in CV Risk Assessment

  Rethinking Cardiovascular Risk: Uncovering the Blind Spots

  • 

    

    Jennifer Caudle, DO, FACOFP

  • 

    

    Javed Butler, MD, MPH, MBA

• 

  RestartResume

  Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection

  Conversations in CV Risk Assessment

  Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection

  • 

    

    Jennifer Caudle, DO, FACOFP

  • 

    

    Javed Butler, MD, MPH, MBA

  • 

    

    Martha Gulati, MD, MS, FACC, FAHA
• advertisement

• 

  RestartResume

  Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table

  Conversations in CV Risk Assessment

  Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table

  • 

    

    Brian P. McDonough, MD, FAAFP

  • 

    

    Javier Morales, MD, FACP, FACE

• 

  RestartResume

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  Medical Industry Feature

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  • 

    

    Jaimini Patel, PharmD, BCCCP

  • 

    

    Sayna Norouzi, MD

• 

  RestartResume

  Expert Opinions on Renal Compensation and Renal Functional Reserve

  Medical Industry Feature

  Expert Opinions on Renal Compensation and Renal Functional Reserve

  • 

    

    Jai Radhakrishnan, MD

  • 

    

    Leal Herlitz, MD

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  • 

    

    Dana Rizk, MD

  • 

    

    Carla Nester, MD

  • 

    

    Sanjeev Sethi, MD, PhD

  • 

    

    Leal Herlitz, MD

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  • 

    

    Dana Rizk, MD

  • 

    

    Carla Nester, MD

  • 

    

    Sanjeev Sethi, MD, PhD

  • 

    

    Leal Herlitz, MD
• advertisement